New research suggests that weight loss injections such as Wegovy and Mounjaro may offer protective benefits against dementia, stroke and premature death in people living with type 2 diabetes and obesity.

Leading UK experts are calling for tighter regulation of weight loss surgery abroad, warning that the booming trade in bariatric medical tourism is placing lives at risk.

Obesity is a known risk factor for stroke, but using body mass index (BMI) alone to assess stroke risk may not be enough. A new international study suggests that better predictors are available — and artificial intelligence could help improve early detection and prevention.

At the recent Blackburn Course in Obesity Medicine, hosted by Harvard Medical School, Dr Harold Bays, Medical Director at the Louisville Metabolic and Atherosclerosis Research Center, highlighted the direct and indirect ways in which obesity increases the risk of cardiovascular disease.

A new study has found that one in five adults living with overweight in the United States could be newly classified as living with obesity under a revised definition developed by the European Association for the Study of Obesity (EASO).

The true cost of the UK’s overweight and obesity crisis has reached an eye-watering £126 billion a year, according to a major new analysis by Frontier Economics for the Nesta think tank.

Childhood obesity has reached "alarming" levels in the UK, prompting leading scientists to call for urgent action to establish healthy habits during the earliest stages of life.

Food retailers and manufacturers will ‘make the healthy choice the easy choice’ in a world-first partnership between government and industry to tackle the obesity epidemic and ease pressure on the NHS as part of the Plan for Change. 

Childhood obesity is set to worsen across England, with new projections revealing that more than half of all 10- and 11-year-olds in nine local authority areas will be living with overweight or obesity by 2035.

With more than a third of adults in parts of Worcestershire living with obesity, the county’s Director of Public Health, Dr Lisa McNally has called for a shift away from finger-pointing and shame – and towards practical, community-based support.

A new study has identified key gaps in current genetic testing approaches for obesity, suggesting that more comprehensive analysis is needed to identify individuals with a genetic predisposition to the condition. The findings highlight the value of whole-exome sequencing over existing obesity gene panels and call for a rethink of current testing criteria.

A London borough is set to introduce a ban on junk food advertising in a move aimed at tackling rising rates of obesity and diabetes.

Full data from two major Phase 3 trials of Novo Nordisk’s investigational weight-loss treatment, CagriSema, show that most side effects were mild to moderate, with positive outcomes reported for weight reduction and blood sugar control.

Mounjaro, the weekly weight-loss injection also known as tirzepatide, will be available through GP surgeries in England from today. However, access to the drug is limited to people who meet tight eligibility criteria, as the NHS takes a phased approach to manage demand and resources.

Novo Nordisk recently presented the results from the phase 3b STEP UP trial for weight management in adults living with obesity without diabetes at the American Diabetes Association (ADA) Scientific Sessions, in Chicago.

Teenage boys who are overweight could be passing on harmful genetic changes to their future children, increasing their risk of conditions such as obesity and asthma, according to new research.

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of researchers has identified a gene that appears to be key for regulating food intake.

Women prescribed GLP-1 weight-loss medications urged to use effective contraception as MHRA highlights reproductive health concerns

A new digital tool aimed at children living with severe obesity is set to be piloted across 15 specialist NHS clinics in England.

The number of US adolescents being prescribed the weight-loss medication Wegovy has surged by 50 per cent in the past year, according to new data, as families and healthcare professionals increasingly consider GLP-1 therapies as part of obesity treatment.